Ereyada shuruudaha bukaanka la wargeliyay
Marka qofku leeyahay lafaha lafaha , mid ka mid ah waxyaabaha ugu horeeya ee uu rabo inuu ogaado waa sida xun ee ay tahay. Si loo go'aamiyo mudnaanta iyo waqtiga daaweynta / dib u soo kabashada, dhakhaatiirta ayaa caadi ahaan samayn doona raajo. Xaaladaha qaarkood, waxay isticmaali karaan farsamooyinka kale ee sawir-baadhista, sida sawir-qaadidda (CT) ama sawir-maskaxda sawirka (MRI ), gaar ahaan waa jajabta neefsiga . Tani waa nooc ka mid ah jabka oo aan sababin dhaawacyo, laakiin xaalad caafimaad oo lumisa lafaha.
Bukaan ahaan, waxaad xaq u leedahay inaad isticmaasho si aad si buuxda u fahanto ikhtiyaarada cudurka iyo daaweyntaada labadaba. Si aad sidaas u yeelatid, si fiican ayaad u adeegi lahayd si aad u fahamtid ereyada loo isticmaalo qeexidda jab.
Qeexida Goobta Jabka
Meelaha dabiiciga ah ee jabka ayaa ku saabsan wax ka badan halka kaliya ee nasashada; waxay qeexeysaa dabeecada qaabdhismeedka fasaxa. Si loo dhammeeyo, dhakhaatiirta ayaa sida caadiga ah isticmaali doona shuruudaha soo socda:
- Diaphyseal: mooska (xarunta) lafta
- Metaphyseal: oo ku yaala dhinaca dambe ee lafta, laakiin aan la wadaagin
- Peri-artticular: ku yaalla dusha sare ee lafta dhamaadka lafta
- Intra-articular: jab ah kaas oo ku sii faafaya wadajir ah iyada oo loo marayo kilyaha
- Proximal: kudhow meel u dhow xarunta dhexe ee dhamaadka lafta
- Distal: meel dheer oo ku yaal bartamaha jirka ee dhamaadka lafaha
Jabka jilicsan ee dusha sare waxaa badanaa laguula dhaqmaa si taxaddar leh iyada oo ciladaha ku habboon ee isku dhafan ay u horseedi karaan xanuunka arthritis-ga ee wadajirka.
Qeexida Xirfad Jabka
Naqshadaynta jabka ayaa inoo sheegeysa sida ay uga fog tahay booska lafaha ay u wareegtay. Dhakhaatiirtu waxay ku tilmaami doonaan ereyada soo socda:
- Hoos-u-barokicin: halka lafta lafa-jabo laakiin isku-dheelitirnaan buuxda
- Ugu yaraa barokac: halka uu jiro isbedel yar oo booska ah, caadi ahaan ma ahan wax muhiim ah
- Barakacay: halkaasoo lafta si aad ah loo rogay, heerka uu ku qeexay boqolleyda
- Murugada: Jabis gudaha ah (wadajir ah) jajab kaas oo la riixay lakulanka lafaha
- Qulqulaya: xagasha ay lafaha la lumiyo, mar labaad ayaa lagu sharraxay heerarka
- Gaabinta: saameyn keena marka muruqyada ku hareereysan ay laf-jebinayaan lafta si adag, si gaabis ah lafta lafta
Qeexidda Jabka Dheeraad ah
Waxaa jira dhowr dhakhtar oo waqti u isticmaali kara sharaxaadda jabka oo sababay dhaawacyo xoog leh sida shil baabuur ama dayrta weyn. Waxaa ka mid ah:
- Isku-kalsoonaanta: jabka ama lafaha lafaha in ka badan laba qaybood oo jajab ah (loona yaqaan 'lafaha')
- Qaybta: lafaha lafaha oo ay ka mid yihiin jajabyo badan oo waaweyn ayaa ka soocaya jirka ugu weyn ee lafta
Aqoonsiga Jabka Jirka
Jabka ka soo baxa wadnaha ayaa keena marka lafaha uu daciifo xanuun sababay xitaa mid ka soo baxa lafaha ama wuxuu farageliyaa dheef-shiid kiimikaadka caadiga ah (dib-u-habeyn) lafta. Dhakhaatiirtu waxay inta badan ku tilmaamaan cilladaha sidan soo socota:
- Osteopenia: xaalad aan jirku lahayn lafo cusub sida ugu dhakhsaha badan ee lafaha hore u soo celiso, marar dhif ah natiijada cudurkan sida hormoon
- Cystic: waxa lagu gartaa abuurista fiixaha sida ay ku dhici karto kansarka lafaha iyo infekshannada aan lahayn kansarka qaarkood
- Lionion: wax aan caadi aheyn oo laga yaabo in ay sababto dhaawac lafaha ama fudud oo laf dhabarka la soo dhaafay
Kormeeridda Dayactirka Lafta
Lafaha jaban ayaa badanaa muujiya calaamadaha bogsashada dhawr isbuuc oo dhaawac ah. Dhakhaatiirtu waxay sharraxayaan tan tan oo qiimaynaysa horumarka dayactirka. Kuwaas waxaa ku jira ereyo sida:
- Jabka jilicsan: kobaca lafaha cusub ee hareeraha nasashada ayaa loo arkaa calaamad wanaagsan oo ah in qaybaha lafaha ay dib u midoobaan
- Iskuxidhin: erey kale oo loo isticmaalo in lagu sharaxo habka caadiga ah ee dayactirka lafta sababtoo ah dib u habeyn
- Dib-u-dhiska midaynta : marka lafaha jilicsan uusan si wacan u bogsanin wareegga wareegga, infekshan, xasilooni la'aan, ama sababo kale
> Isha:
> Marsh, J. "OTA Jajabka Jabka". Wargeyska Dhaawaca Orthopedic. 2009; 23 (8): 551. DOI: 10.1097 / BOT.0b013e3181ad5e92.